Breast cancer screening controversies: Who, when, why, and how?

Alison Chetlen, Julie Mack, Tiffany Chan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.

Original languageEnglish (US)
Pages (from-to)279-282
Number of pages4
JournalClinical Imaging
Volume40
Issue number2
DOIs
StatePublished - Mar 1 2016

Fingerprint

Early Detection of Cancer
Breast Neoplasms
Mammography
Breast
Molecular Imaging
Mortality
Magnetic Resonance Imaging

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

@article{593544c52c2a441882560dbf00449083,
title = "Breast cancer screening controversies: Who, when, why, and how?",
abstract = "Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.",
author = "Alison Chetlen and Julie Mack and Tiffany Chan",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.clinimag.2015.05.017",
language = "English (US)",
volume = "40",
pages = "279--282",
journal = "Clinical Imaging",
issn = "0899-7071",
publisher = "Elsevier Inc.",
number = "2",

}

Breast cancer screening controversies : Who, when, why, and how? / Chetlen, Alison; Mack, Julie; Chan, Tiffany.

In: Clinical Imaging, Vol. 40, No. 2, 01.03.2016, p. 279-282.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Breast cancer screening controversies

T2 - Who, when, why, and how?

AU - Chetlen, Alison

AU - Mack, Julie

AU - Chan, Tiffany

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.

AB - Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.

UR - http://www.scopus.com/inward/record.url?scp=84960805807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960805807&partnerID=8YFLogxK

U2 - 10.1016/j.clinimag.2015.05.017

DO - 10.1016/j.clinimag.2015.05.017

M3 - Article

C2 - 26093511

AN - SCOPUS:84960805807

VL - 40

SP - 279

EP - 282

JO - Clinical Imaging

JF - Clinical Imaging

SN - 0899-7071

IS - 2

ER -